Morningstar Investment Management LLC Buys Shares of 3,279 CVS Health Co. (NYSE:CVS)

Morningstar Investment Management LLC bought a new stake in CVS Health Co. (NYSE:CVSGet Rating) during the fourth quarter, Holdings reports. The fund bought 3,279 shares of the pharmacy operator’s stock, valued at approximately $306,000.

Other institutional investors also recently modified their holdings of the company. VitalStone Financial LLC acquired a new stake in CVS Health in the 4th quarter valued at $28,000. Godsey & Gibb Inc. bought a new position in CVS Health in the 4th quarter valued at $28,000. Castleview Partners LLC raised its position in CVS Health by 227.8% in the 4th quarter. Castleview Partners LLC now owns 318 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 221 shares during the last quarter. Mendota Financial Group LLC bought a new position in CVS Health in the 4th quarter valued at $31,000. Finally, EWG Elevate Inc. bought a new position in CVS Health in the 4th quarter valued at $32,000. Institutional investors and hedge funds own 77.29% of the company’s stock.

Analyst Ratings Changes

CVS has been the subject of several research analyst reports. Raymond James cut their price objective on CVS Health from $115.00 to $110.00 and set an “outperform” rating for the company in a research report on Thursday, February 9th. 92 Resources restated a “maintains” rating on shares of CVS Health in a research report on Monday, May 8th. Barclays dropped their price objective on CVS Health from $100.00 to $90.00 in a report on Thursday, May 4th. Jefferies Financial Group boosted their target price on CVS Health from $130.00 to $143.00 and gave the company a “buy” rating in a research note on Thursday, February 9th. Finally, Sanford C. Bernstein decreased their target price on CVS Health from $107.00 to $93.00 in a research note on Tuesday, May 2nd. Three investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $108.75.

CVS Health Trading Down 0.8 %

NYSE:CVS traded down $0.53 during trading hours on Friday, hitting $67.14. 2,828,791 shares of the company were exchanged, compared to its average volume of 8,903,701. The stock has a market capitalization of $86.08 billion, a price-to-earnings ratio of 22.44, a price-to-earnings-growth ratio of 1.25 and a beta of 0.61. The company has a current ratio of 0.92, a quick ratio of 0.67 and a debt-to-equity ratio of 0.79. CVS Health Co. has a one year low of $66.61 and a one year high of $107.26. The company has a fifty day simple moving average of $72.74 and a 200 day simple moving average of $84.92.

CVS Health (NYSE:CVSGet Rating) last posted its quarterly earnings data on Wednesday, May 3rd. The pharmacy operator reported $2.20 earnings per share for the quarter, topping the consensus estimate of $2.07 by $0.13. CVS Health had a return on equity of 15.75% and a net margin of 1.20%. The firm had revenue of $85.28 billion during the quarter, compared to analyst estimates of $80.67 billion. During the same period last year, the company posted $2.22 EPS. The business’s quarterly revenue was up 11.0% on a year-over-year basis. Sell-side analysts expect that CVS Health Co. will post 8.63 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, May 1st. Stockholders of record on Friday, April 21st were paid a $0.605 dividend. The ex-dividend date of this dividend was Thursday, April 20th. This represents a $2.42 annualized dividend and a dividend yield of 3.60%. CVS Health’s dividend payout ratio is presently 79.87%.

Insider Activity

In other news, CEO Karen S. Lynch bought 14,000 shares of CVS Health stock in a transaction dated Wednesday, May 3rd. The stock was bought at an average cost of $69.75 per share, for a total transaction of $976,500.00. Following the purchase, the chief executive officer now directly owns 431,392 shares in the company, valued at approximately $30,089,592. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.25% of the stock is currently owned by company insiders.

CVS Health Company Profile

(Get Rating)

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Pharmacy Services, Retail or Long-Term Care, Health Care Benefits, and Corporate and Other. The Pharmacy Services segment focuses on the pharmacy benefit management solutions.

Recommended Stories

Want to see what other hedge funds are holding CVS? Visit to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSGet Rating).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with's FREE daily email newsletter.